Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1NEO-FRADIN

02 2PREDNISOLONE SODIUM PHOSPHATE

03 7RANITIDINE HYDROCHLORIDE

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

PREDNISOLONE SODIUM PHOSPHATE

Drug : PREDNISOLONE SODIUM PHOSPHATE

Dosage Form : SOLUTION; ORAL

Application Number : 91396

Country : US

Patented : No

Mission Pharmacal

02

arrow
2024 ACI Convention
Not Confirmed

03

arrow
2024 ACI Convention
Not Confirmed

04

arrow
2024 ACI Convention
Not Confirmed

05

arrow
2024 ACI Convention
Not Confirmed

06

arrow
2024 ACI Convention
Not Confirmed

07

arrow
2024 ACI Convention
Not Confirmed
U.S.A
arrow
2024 ACI Convention
Not Confirmed

PREDNISOLONE SODIUM PHOSPHATE

Drug : PREDNISOLONE SODIUM PHOSPHATE

Dosage Form : SOLUTION; ORAL

Application Number : 78988

Country : US

Patented : No

blank

08

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

RANITIDINE HYDROCHLORIDE

Drug : RANITIDINE HYDROCHLORIDE

Dosage Form : SYRUP; ORAL

Application Number : 90054

Country : US

Patented : No

blank

09

arrow
2024 ACI Convention
Not Confirmed

10

arrow
2024 ACI Convention
Not Confirmed